The Manufacturers Life Insurance Company Has $24.56 Million Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

The Manufacturers Life Insurance Company reduced its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 29.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 134,759 shares of the medical instruments supplier's stock after selling 57,512 shares during the period. The Manufacturers Life Insurance Company owned approximately 0.55% of ICU Medical worth $24,556,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of ICUI. SG Americas Securities LLC boosted its stake in shares of ICU Medical by 441.7% during the 2nd quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after buying an additional 4,744 shares during the last quarter. LMR Partners LLP acquired a new position in shares of ICU Medical during the 3rd quarter valued at about $3,884,000. Savant Capital LLC acquired a new position in shares of ICU Medical during the second quarter worth approximately $431,000. Boston Partners acquired a new stake in ICU Medical during the first quarter worth $790,000. Finally, Jane Street Group LLC increased its position in shares of ICU Medical by 79.7% during the 1st quarter. Jane Street Group LLC now owns 89,852 shares of the medical instruments supplier's stock worth $9,643,000 after purchasing an additional 39,839 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

Insider Buying and Selling at ICU Medical

In other news, COO Christian B. Voigtlander sold 1,962 shares of the firm's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David C. Greenberg sold 972 shares of the firm's stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total value of $153,682.92. Following the sale, the director now directly owns 5,037 shares of the company's stock, valued at $796,400.07. This trade represents a 16.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 40,364 shares of company stock valued at $6,876,478 over the last quarter. Corporate insiders own 6.70% of the company's stock.

Wall Street Analysts Forecast Growth

ICUI has been the topic of several analyst reports. StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. Raymond James boosted their target price on ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a research report on Thursday, September 12th. Jefferies Financial Group began coverage on ICU Medical in a research report on Monday, October 14th. They issued a "hold" rating and a $183.00 price objective on the stock. Finally, KeyCorp upped their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 13th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, ICU Medical currently has an average rating of "Moderate Buy" and a consensus target price of $173.00.

ICU Medical Trading Up 2.6 %

Shares of ICUI stock traded up $4.21 during trading hours on Friday, hitting $163.96. The company had a trading volume of 159,148 shares, compared to its average volume of 261,729. ICU Medical, Inc. has a fifty-two week low of $83.26 and a fifty-two week high of $196.26. The company's fifty day moving average is $174.60 and its 200 day moving average is $147.37. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock has a market capitalization of $4.01 billion, a PE ratio of -35.88 and a beta of 0.66.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.